Finanzas de Inogen Inc (INGN)INGNInogen Inc

Evaluating the bottom line, Inogen, Inc. maintains a gross margin of 45.51%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -5.13%, while the net margin is -4.05%. These profitability ratios, combined with a Return on Equity (ROE) of -13.14%, provide a clear picture of how effectively INGN converts its operational activities into shareholder value.

In the context of the broader market, INGN competes directly with industry leaders such as PDEX and STIM. With a market capitalization of $180.60M, it holds a significant position in the sector. When comparing efficiency, INGN's gross margin of 45.51% stands against PDEX's 33.35% and STIM's 52.17%. Such benchmarking helps identify whether Inogen, Inc. is trading at a premium or discount relative to its financial performance.

Inogen's revenue for Q1 2026 was $85.1 million, a 3.4% year-over-year increase, indicating some growth. However, the company has reported consistent net losses, with a net income of -3.85 million in Q2 2026. The gross margin is relatively strong at 45.51%, showing that the company can maintain profitability on its sales despite the losses.